These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1666 related items for PubMed ID: 24267732

  • 1. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H, Yamauchi H, Tsugawa K, Hayashi N, Yoshida A, Kajiura Y, In R, Matsuda N, Nakamura S.
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [Abstract] [Full Text] [Related]

  • 2. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.
    Park S, Park JM, Cho JH, Park HS, Kim SI, Park BW.
    Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483
    [Abstract] [Full Text] [Related]

  • 3. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K, Ishikawa T, Yamada A, Shimizu D, Tanabe M, Sasaki T, Ichikawa Y, Endo I.
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [Abstract] [Full Text] [Related]

  • 4. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J, Dueñas-Rodríguez B, Luque-López C, Ramírez-Expósito MJ, Martínez-Ferrol J, Ruíz-Mateas A, Ureña C, Carrera-González MP, Mayas MD, Martínez-Martos JM.
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [Abstract] [Full Text] [Related]

  • 5. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J.
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [Abstract] [Full Text] [Related]

  • 6. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
    Park S, Lee JE, Paik HJ, Ryu JM, Bae SY, Lee SK, Kim SW, Nam SJ.
    Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
    [Abstract] [Full Text] [Related]

  • 7. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [Abstract] [Full Text] [Related]

  • 8. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
    Gatek J, Vrana D, Hnatek L, Bakala J, Dudesek B, Duben J, Musil T.
    J BUON; 2012 Oct; 17(2):265-70. PubMed ID: 22740204
    [Abstract] [Full Text] [Related]

  • 9. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.
    Yu Y, Cui N, Li HY, Wu YM, Xu L, Fang M, Sheng Y.
    BMC Cancer; 2016 Oct 18; 16(1):808. PubMed ID: 27756234
    [Abstract] [Full Text] [Related]

  • 10. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
    Javid S, Segara D, Lotfi P, Raza S, Golshan M.
    Ann Surg Oncol; 2010 Jul 18; 17(7):1841-6. PubMed ID: 20143266
    [Abstract] [Full Text] [Related]

  • 11. Axillary sentinel node biopsy after neoadjuvant chemotherapy.
    Ozmen V, Unal ES, Muslumanoglu ME, Igci A, Canbay E, Ozcinar B, Mudun A, Tunaci M, Tuzlali S, Kecer M.
    Eur J Surg Oncol; 2010 Jan 18; 36(1):23-9. PubMed ID: 19931375
    [Abstract] [Full Text] [Related]

  • 12. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H, Headon H, Kasem A, Mokbel K.
    Anticancer Res; 2016 Apr 18; 36(4):1461-71. PubMed ID: 27069121
    [Abstract] [Full Text] [Related]

  • 13. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K, Watanabe C, Nakamura S, Ogiya A, Osako T, Akiyama F, Yoshimura A, Iwata H, Ohno S, Kojima Y, Tsugawa K, Motomura K, Hayashi N, Yamauchi H, Sato N.
    Clin Breast Cancer; 2016 Aug 18; 16(4):299-304. PubMed ID: 26993216
    [Abstract] [Full Text] [Related]

  • 14. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Péley G, Török K, Farkas E, Mátrai Z, Horváth Z, Sinkovics I, Hitre E, Rényi-Vámos F, Orosz Z, Köves I.
    Magy Onkol; 2006 Aug 18; 50(1):19-23. PubMed ID: 16617379
    [Abstract] [Full Text] [Related]

  • 15. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T, Takasugi M, Iwamoto E, Akashi-Tanaka S, Fukutomi T, Terui S.
    Am J Surg; 2006 Feb 18; 191(2):225-9. PubMed ID: 16442950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF, Tannebaum JE, Jernigan AM, Palazzo JP.
    Cancer; 2010 Mar 01; 116(5):1243-51. PubMed ID: 20087958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 84.